Education
About Us
Working with TipRanks
Follow Us
Vitrolife AB (SE:VITR)
:VITR
VITR Stock Chart & Stats
kr133.40
-kr3.40(-1.91%)
At close: 4:00 PM EST
kr133.40
-kr3.40(-1.91%)
Day’s Range― - ―
52-Week Rangekr126.30 - kr251.00
Previous CloseN/A
Volume81.91K
Average Volume (3M)92.36K
Market Cap
kr18.19B
Enterprise Valuekr20.03B
Total Cash (Recent Filing)kr1.11B
Total Debt (Recent Filing)kr2.00B
Price to Earnings (P/E)41.2
Beta0.56
Next Earnings
Feb 03, 2026EPS Estimate
1.11Next Dividend Ex-DateN/A
Dividend Yield0.82%
Share Statistics
EPS (TTM)0.75
Shares Outstanding135,447,190
10 Day Avg. Volume105,869
30 Day Avg. Volume92,365
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)2.13
Price to Sales (P/S)8.07
P/FCF Ratio32.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vitrolife AB News
VITR FAQ
What was Vitrolife AB’s price range in the past 12 months?
Vitrolife AB lowest stock price was kr126.30 and its highest was kr251.00 in the past 12 months.
What is Vitrolife AB’s market cap?
Vitrolife AB’s market cap is kr18.19B.
When is Vitrolife AB’s upcoming earnings report date?
Vitrolife AB’s upcoming earnings report date is Feb 03, 2026 which is in 47 days.
How were Vitrolife AB’s earnings last quarter?
Vitrolife AB released its earnings results on Oct 23, 2025. The company reported kr0.75 earnings per share for the quarter, missing the consensus estimate of kr0.947 by -kr0.197.
Is Vitrolife AB overvalued?
According to Wall Street analysts Vitrolife AB’s price is currently Overvalued.
Does Vitrolife AB pay dividends?
Vitrolife AB pays a Annually dividend of kr1.1 which represents an annual dividend yield of 0.82%. See more information on Vitrolife AB dividends here
What is Vitrolife AB’s EPS estimate?
Vitrolife AB’s EPS estimate is 1.11.
How many shares outstanding does Vitrolife AB have?
Vitrolife AB has 135,447,190 shares outstanding.
What happened to Vitrolife AB’s price movement after its last earnings report?
Vitrolife AB reported an EPS of kr0.75 in its last earnings report, missing expectations of kr0.947. Following the earnings report the stock price went up 2.069%.
Which hedge fund is a major shareholder of Vitrolife AB?
Currently, no hedge funds are holding shares in SE:VITR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vitrolife AB
Vitrolife AB (VITR) is a global leader in the field of assisted reproductive technologies and the development of tools and services for in vitro fertilization (IVF). The company specializes in creating high-quality culture media, cryopreservation solutions, and other essential products that support fertility clinics and healthcare providers in optimizing the chances of successful pregnancies. Vitrolife operates within the life sciences sector, focusing on improving reproductive health through innovation and research in reproductive biology.
Technical Analysis
Getinge
―
BICO Group AB Class B
―
CellaVision AB
―
Xvivo Perfusion AB
―
Sectra AB Class B
―
Options Prices
Currently, No data available
---